95 related articles for article (PubMed ID: 3975177)
21. Diffusion of ciprofloxacin into prostatic fluid.
Dalhoff A; Weidner W
Eur J Clin Microbiol; 1984 Aug; 3(4):360-2. PubMed ID: 6489327
[TBL] [Abstract][Full Text] [Related]
22. Penicillanic acid derivatives in the canine prostate.
Nielsen OS; Frimodt-Moeller N; Maigaard S; Hoyme U; Baumueller A; Madsen PO
Prostate; 1980; 1(1):79-85. PubMed ID: 6269107
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.
Naber KG; Sörgel F
Andrologia; 2003 Oct; 35(5):331-5. PubMed ID: 14535866
[TBL] [Abstract][Full Text] [Related]
24. Penetration of rufloxacin into human prostatic tissue and fluid.
Boerema JB; Bach D; Jol C; Pahlmann W
J Antimicrob Chemother; 1991 Oct; 28(4):547-54. PubMed ID: 1662190
[TBL] [Abstract][Full Text] [Related]
25. In-vitro sensitivity of legionellas and mycoplasmas to amifloxacin.
Fallon RJ
J Antimicrob Chemother; 1988 Mar; 21(3):381-2. PubMed ID: 3360698
[No Abstract] [Full Text] [Related]
26. Nitroimidazoles in the canine prostate, vagina, and urethra.
Nielsen OS; Frimodt-Møller N; Maigaard S; Madsen PO
Prostate; 1981; 2(1):71-8. PubMed ID: 7279813
[TBL] [Abstract][Full Text] [Related]
27. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
[TBL] [Abstract][Full Text] [Related]
28. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
29. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
[TBL] [Abstract][Full Text] [Related]
30. Determination of amifloxacin and two of its principal metabolites in plasma and urine by high-performance liquid chromatography using automated column switching.
Crawmer BP; Cook JA; Brown RR
J Chromatogr; 1990 Sep; 530(2):407-17. PubMed ID: 2127781
[TBL] [Abstract][Full Text] [Related]
31. Rosoxacin distribution in kidney and prostate: experimental studies in dogs.
Maigaard S; Frimodt-Möller N; Madsen PO
Urol Res; 1980; 8(2):113-6. PubMed ID: 7394950
[No Abstract] [Full Text] [Related]
32. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
Naber KG; Sörgel F; Kees F; Schumacher H; Metz R; Grobecker H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():199-207. PubMed ID: 2462556
[TBL] [Abstract][Full Text] [Related]
33. Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion.
Madsen PO; Baumueller A; Hoyme U
Scand J Infect Dis Suppl; 1978; (14):145-50. PubMed ID: 279967
[TBL] [Abstract][Full Text] [Related]
34. Diffusion of tosufloxacin into prostatic tissue.
Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
[TBL] [Abstract][Full Text] [Related]
35. Concentration of ciprofloxacin in human prostatic tissue after oral administration.
Dan M; Golomb J; Gorea A; Braf Z; Berger SA
Antimicrob Agents Chemother; 1986 Jul; 30(1):88-9. PubMed ID: 2944481
[TBL] [Abstract][Full Text] [Related]
36. Co-trimazine distribution in the canine prostate.
Frimodt-Möller N; Maigaard S; Madsen PO; Naber KG
Infection; 1979; 7 Suppl 4():S345-8. PubMed ID: 511347
[TBL] [Abstract][Full Text] [Related]
37. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
[TBL] [Abstract][Full Text] [Related]
38. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.
Hoogkamp-Korstanje JA; van Oort HJ; Schipper JJ; van der Wal T
J Antimicrob Chemother; 1984 Dec; 14(6):641-5. PubMed ID: 6440885
[TBL] [Abstract][Full Text] [Related]
39. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Oliveira AD; D'Azevedo PA; Francisco W
Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
